Methods: In this double-blind trial, we enrolled 1961 adults with a body-mass index (the weight in kilograms divided by the square of the height in meters) of 30 or greater (27 in persons with 1 weight-related coexisting condition), who did not have diabetes, and randomly assigned them, in a 2:1 ratio, to 68 weeks of treatment with once-weekly subcutaneous semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
Diabetes & Metabolic Syndrome
We keep looking for straw men to blame: must be all the glutathione, must be her star lifestyle, must be everything else, other than that which should not be named (VACsorry, VOLDEMORT!) Here is the latest paper on the topic, published in World Journal of Cardiology, Feb 2025, titled Risk stratification for future cardiac arrest after COVID-19 vaccination. It reports Small patches of inflammation and/or edema can be missed on cardiac imaging and autopsy, and the heart can appear grossly normal
Peptide Injections: Emerging but Limited Evidence Peptides are short chains of amino acids that regulate biological functions, including tissue repair and regeneration
Supply shortages The global semaglutide shortage that began in 2022 and persisted through much of 2024 pushed many people toward alternative sources
